+1 (314) 370-6046 oderKontakt

Anti-Kir6.2 Antikörper

8 Products

Kir6.2 ist ein Gen, das durch das Symbol KCNJ11 kodiert wird. Im Allgemeinen auch bezeichnet als: ATP-sensitive inward rectifier potassium channel 11; IKATP; Inward rectifier K(+) channel Potassium channel, inwardly rectifying subfamily J member 11; KCNJ11. Kir6.2 hat eine Masse von 43.54kDa, eine Aminosäurelänge von 390, und ist an folgenden Krankheiten beteiligt: Familial hyperinsulinemic hypoglycemia 2; Diabetes mellitus, permanent neonatal; Transient neonatal diabetes mellitus 3; Maturity-onset diabetes of the young 13.

Wir bieten 8 antikörper gegen Kir6.2, aufgewachsen in Kaninchen und Ziege, welche geeignet sind für WB, IHC, ELISA and ICC/IF mit Proben abgeleitet von Human, Maus und Ratte.

Gen- und Proteininformationen

UniProt Zusammenfassung
This receptor is controlled by G proteins. Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it. Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages. The inward rectification is mainly due to the blockage of outward current by internal magnesium. Can be blocked by extracellular barium (By similarity). Subunit of ATP-sensitive potassium channels (KATP). Can form cardiac and smooth muscle-type KATP channels with ABCC9. KCNJ11 forms the channel pore while ABCC9 is required for activation and regulation.
Entrez Zusammenfassung
Potassium channels are present in most mammalian cells, where they participate in a wide range of physiologic responses. The protein encoded by this gene is an integral membrane protein and inward-rectifier type potassium channel. The encoded protein, which has a greater tendency to allow potassium to flow into a cell rather than out of a cell, is controlled by G-proteins and is found associated with the sulfonylurea receptor SUR. Mutations in this gene are a cause of familial persistent hyperinsulinemic hypoglycemia of infancy (PHHI), an autosomal recessive disorder characterized by unregulated insulin secretion. Defects in this gene may also contribute to autosomal dominant non-insulin-dependent diabetes mellitus type II (NIDDM), transient neonatal diabetes mellitus type 3 (TNDM3), and permanent neonatal diabetes mellitus (PNDM). Multiple alternatively spliced transcript variants that encode different protein isoforms have been described for this gene.
Rolle bei Krankheiten
Familial hyperinsulinemic hypoglycemia 2: Most common cause of persistent hypoglycemia in infancy. Unless early and aggressive intervention is undertaken, brain damage from recurrent episodes of hypoglycemia may occur.

Diabetes mellitus, permanent neonatal: A rare form of diabetes distinct from childhood-onset autoimmune diabetes mellitus type 1. It is characterized by insulin-requiring hyperglycemia that is diagnosed within the first months of life. Permanent neonatal diabetes requires lifelong therapy.

Transient neonatal diabetes mellitus 3: Neonatal diabetes mellitus, defined as insulin-requiring hyperglycemia within the first month of life, is a rare entity. In about half of the neonates, diabetes is transient and resolves at a median age of 3 months, whereas the rest have a permanent form of diabetes. In a significant number of patients with transient neonatal diabetes mellitus, diabetes type 2 appears later in life. The onset and severity of TNDM3 is variable with childhood-onset diabetes, gestational diabetes or adult-onset diabetes described.

Maturity-onset diabetes of the young 13: A form of diabetes that is characterized by an autosomal dominant mode of inheritance, onset in childhood or early adulthood (usually before 25 years of age), a primary defect in insulin secretion and frequent insulin-independence at the beginning of the disease.
Sequenzähnlichkeiten
Belongs to the inward rectifier-type potassium channel (TC 1.A.2.1) family. KCNJ11 subfamily.
Posttranslationale Modifikation
Phosphorylation by MAPK1 results in changes in channel gating that destabilize the closed states and reduce the ATP sensitivity.
Zellort
Membrane.
Western Blot - Anti-Kir6.2 Antibody (B1084) - Antibodies.com
(5)
Produkt anzeigen10µg Versuchsgrößen
Western Blot - Anti-Kir6.2 (phospho Thr224) Antibody (A1084) - Antibodies.com
(3)
Produkt anzeigen10µg Versuchsgrößen
Western Blot - Anti-KCNJ11 Antibody (A83251) - Antibodies.com
(2)
Western Blot - Anti-Kcnj11 Antibody (A84342) - Antibodies.com
(2)
ELISA - Anti-Kir6.2 (phospho Thr224) Antibody (P12-1131) - Antibodies.com
(2)
Produkt anzeigen10µg Versuchsgrößen
Anti-Kir6.2 (V220) Antibody from Bioworld Technology (BS2641) - Antibodies.com
(2)
Western blot - Kir6.2 (Phospho-Thr224) Antibody from Signalway Antibody (12108) - Antibodies.com
(2)
Western blot - KCNJ11 Antibody from Signalway Antibody (33027) - Antibodies.com

Zeigt 1-8 von 8 Produkten

Suchfilter Hauptmenü Kontakt 0Kasse
Oben